Literature DB >> 28679606

Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa.

Sally H Pattison1, David S Gibson2,3, Elinor Johnston2, Samantha Peacock4, Keith Rivera4, Michael M Tunney5, Darryl J Pappin4, J Stuart Elborn2,6.   

Abstract

Lung disease is the main cause of morbidity and mortality in cystic fibrosis (CF), and involves chronic infection and perturbed immune responses. Tissue damage is mediated mostly by extracellular proteases, but other cellular proteins may also contribute to damage through their effect on cell activities and/or release into sputum fluid by means of active secretion or cell death.We employed MudPIT (multidimensional protein identification technology) to identify sputum cellular proteins with consistently altered abundance in adults with CF, chronically infected with Pseudomonas aeruginosa, compared with healthy controls. Ingenuity Pathway Analysis, Gene Ontology, protein abundance and correlation with lung function were used to infer their potential clinical significance.Differentially abundant proteins relate to Rho family small GTPase activity, immune cell movement/activation, generation of reactive oxygen species, and dysregulation of cell death and proliferation. Compositional breakdown identified high abundance of proteins previously associated with neutrophil extracellular traps. Furthermore, negative correlations with lung function were detected for 17 proteins, many of which have previously been associated with lung injury.These findings expand our current understanding of the mechanisms driving CF lung disease and identify sputum cellular proteins with potential for use as indicators of disease status/prognosis, stratification determinants for treatment prescription or therapeutic targets.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28679606     DOI: 10.1183/13993003.01569-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  A Flow Cytometric Method for Isolating Cystic Fibrosis Airway Macrophages from Expectorated Sputum.

Authors:  Katherine B Hisert; W Conrad Liles; Anne M Manicone
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

Review 2.  Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?

Authors:  Maura D'Amato; Paolo Iadarola; Simona Viglio
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

3.  Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition.

Authors:  Holly R Keir; Christopher J Fong; Megan L Crichton; Philip Barth; Eric Chevalier; Gill Brady; Gwen Kennedy; Johann Zimmermann; Piet L B Bruijnzeel; Alison J Dicker; James D Chalmers
Journal:  ERJ Open Res       Date:  2019-03-25

4.  Culture with apically applied healthy or disease sputum alters the airway surface liquid proteome and ion transport across human bronchial epithelial cells.

Authors:  Maximillian Woodall; Boris Reidel; Mehmet Kesimer; Robert Tarran; Deborah L Baines
Journal:  Am J Physiol Cell Physiol       Date:  2021-10-06       Impact factor: 4.249

5.  Cystic Fibrosis Sputum Impairs the Ability of Neutrophils to Kill Staphylococcus aureus.

Authors:  Kayla Fantone; Samantha L Tucker; Arthur Miller; Ruchi Yadav; Eryn E Bernardy; Rachel Fricker; Arlene A Stecenko; Joanna B Goldberg; Balázs Rada
Journal:  Pathogens       Date:  2021-06-04

6.  Serum-Based Proteomics Profiling in Adult Patients with Cystic Fibrosis.

Authors:  Hicham Benabdelkamel; Hanadi Alamri; Meshail Okla; Afshan Masood; Mai Abdel Jabar; Ibrahim O Alanazi; Assim A Alfadda; Imran Nizami; Majed Dasouki; Anas M Abdel Rahman
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

Review 7.  Metaproteomics to Decipher CF Host-Microbiota Interactions: Overview, Challenges and Future Perspectives.

Authors:  Pauline Hardouin; Raphael Chiron; Hélène Marchandin; Jean Armengaud; Lucia Grenga
Journal:  Genes (Basel)       Date:  2021-06-09       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.